Xavier Andrade-Gonzalez MD @XavierAndradeG X Profile

Xavier Andrade-Gonzalez MD

@XavierAndradeG

Followers

241

Following

184

Media

5

Statuses

148

Hematologist with focus on hematological malignancies, BMT and Cellular Therapy | Mayo Clinic Alumni | Tweets are my own.

Sioux Falls, SD

Joined February 2012

Don't wanna be here? Send us removal request.

Radhika Bansal Rakshit (She/Her)

@Radhika_Bansl

3 years

Late night dinner hunt with the troop #Tandem2023 ⁦@E_D_Bezerra⁩ ⁦@XavierAndradeG⁩ ⁦@Leo_Reona_Sake⁩ ⁦@Gabetasanchez⁩

1

12

Radhika Bansal Rakshit (She/Her)

@Radhika_Bansl

3 years

@MayoCancerCare three site data on prognostic value of BM & PET #MRD in CART #TCellRx @MayoMyeloma #mmsm @ASH_hematology #ASH2022 @YiLinMDPhD @myelomaMD @MayoMrfa ⏰Monday, 11:45 AM 📍 Room 393-396 😊 See you all! 😊

1

5

14

Ohio State Hematology

@OSUHematology

4 years

Excited to announce that @E_D_Bezerra will be joining the @OSUCCC_James team this summer from the Mayo Clinic in our #BMT and #CellularTherapy program. We're thrilled to bring his expertise and clinical care to @osuwexmed @Pelotonia

3

5

38

Jorge G. Ortiz-Garcia, MD, MSCR, FAAN

@Jorge_Ortiz_G

4 years

Un gusto compartir con los estudiantes de la @ucatolicagye en este Primer Curso Virtual de Neurología. Gracias a @neurologiagye por la organización. Un honor compartir conferencias con dos grandes colegas y amigos @vdelbrutto y Patricio Valle . . #Neurologia #Neurocirugia

1

3

32

Yi Lin

@YiLinMDPhD

4 years

#ASH21 @YucaiWangMD presents on the largest cohort of RWE Tecartus in MCL from US Lymphoma CART Consortium @ASH_Hematology @MaurerStats @MayoCancerCare @MichaelDJain @DrFredLocke @michaelwangmd Dr. Sattva Neelapu, Dr. David Miklos. Congrats to all authors!

0

6

36

Paul Hampel

@hampel_p

4 years

Cell therapy extraordinaire @E_D_Bezerra sharing some exciting data from the @kenderian_ss lab working to optimize CAR T! #lymsm #ASH21 #ASHKudos @MayoCancerCare @MayoHemeOnc

1

4

42

Zhuoer (Zoey) Xie, MD, MSCR

@ZhuoerXie

4 years

Thank you to the opportunity! Such an amazing session to know and learn from the experts🙏🙏

Amer Zeidan MBBS,MHS ‏عامر زيدان

@Dr_AmerZeidan

4 years

Fantastic talk by @zhuoerxie in #ASH21 about #CCUS and pre-#MDSsm states in the @MDSFoundation

1

3

20

Xavier Andrade-Gonzalez MD

@XavierAndradeG

5 years

No hay palabras... qué grande Barcelona! Campeón y vuelta olímpica donde hace años se merecía. Aunque apaguen las luces, fue la noche donde brilló el sol... Salud Campeón ⚽️🏆

0

2

Jorge G. Ortiz-Garcia, MD, MSCR, FAAN

@Jorge_Ortiz_G

5 years

NINDS trial was published 25 years ago. The t-PA revolutioned the stroke treatment. A Milestone in the history of Neurology. Today, t-PA is used with or without mechanical thrombectomy. Stroke is more treatable than ever, but time is crucial, “TIME IS BRAIN” #Neurology #Stroke

2

35

108

Xavier Andrade-Gonzalez MD

@XavierAndradeG

5 years

Honored to present our findings. Ferritin as a simple, widely available test to enhance pre-alloSCT risk-stratification tools in patients with MF. #ASH20 #Allosct #myelofibrosis #mpnsm

Harry Fuentes MD MSc

@hfuentesbayne

5 years

Proud of my esteemed colleague @XavierAndradeG. Check his #ASH2020 poster on novel prognostic markers in pts w/ MF @CaThompsonMD @AMarshallMD @MayoHemeOnc @MayoClinic @MrinalPatnaik @VincentRK @VillasboasJC @rleonferre @n_gangat @MRLitzow @AntoineNSaliba @MayoCancerCare @AlkaliDr

1

21

Xavier Andrade-Gonzalez MD

@XavierAndradeG

5 years

Interesting work by @UDurani. COVID-19 ⬆️burnout (BO) on hem-onc trainees. Highest risk was pre-existing BO. Interestingly, preCOVID burnout prevalence was 22%!! Maybe the pandemic just highlighted a bigger problem here.. #MedEd #ASH20 #ASHKudos

0

1

5

Xavier Andrade-Gonzalez MD

@XavierAndradeG

5 years

Outstanding poster by @AntoineNSaliba on hematologic immune-related adverse events in patients on ICI therapy. Median time-to-irAE: 18 days. AIHA most common (41%). 53% responded to steroids alone, 33% need additional Rx. Carefully select pts. to rechallenge. #ASH20

1

2

17

Xavier Andrade-Gonzalez MD

@XavierAndradeG

5 years

Excellent presentation covering challenging situations in patients with DLBCL. Glad to see "real world" scenarios covered. That said, we still need to improve our standarized tools to assess fitness. #ASH20 #DLBCL

Gaurav Goyal

@GauravGoyalMD

5 years

Really enjoyed this session on elderly DLBCL. Lots of learning: 1. High TRM post C1 2. Role of prephase steroids in reducing TRM at C1 3. Consideration of doses between full RCHOP and RminiCHOP - “the sweet spot” 4. Select elderly patients can get full dose doxo #ASH20 #lymsm

0

2

Mrinal Patnaik

@MrinalPatnaik

5 years

Very grateful to @ASH_hematology for giving due recognition to #MDSMPN overlap syndromes| Several exciting papers #CMML #JMML #MDSMPNRST| @raphaelitzykson Dacota study- lack of benefit of HMA in #MPNCMML @MoritzBinderMD ssRNA ssATAC in #ASXL1mtCMML @MayoClinicCIM

3

18

93

Jonathan Friedberg

@DrJFriedberg

5 years

Max Topp: Great scientific session on bispecific antiCD20’s #ASH2020 CRs reported post CAR-T. Several exciting options, in indolent and aggressive lymphomas.

0

3

20

Xavier Andrade-Gonzalez MD

@XavierAndradeG

5 years

Excelente presentacion del Servicio de Hematologia del #HospitalLuisVernaza en la reunion anual de la Sociedad Americana de Hematologia. Que orgullo! Felicitaciones! 👏@CarlosPlazaM @BrennerSabando @ALEPOSLI

0

1

7

Xavier Andrade-Gonzalez MD

@XavierAndradeG

13 years

Volvimos a la infancia! Aguanten los baberooos!! #calçotada http://t.co/nJGYWsGHHU

0

Xavier Andrade-Gonzalez MD

@XavierAndradeG

13 years

Congreso infecciones BCN http://t.co/gfTMfCXtS5

1

0